Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Goldman's Haider: Pivotal Year for Obesity Market in Pharma
Asad Haider, head of the U.S. Healthcare Business Unit at Goldman Sachs Research, says 2026 is a pivotal year for the obesity market due to upcoming oral drug launches. He tells Romaine Bostick and Katie Greifeld on “The Close” that…
Jobs Report, Big Tech and Pharma Earnings: What to Watch This Week
Earnings season marches on. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report this week, following on the heels of disappointing results from Microsoft that helped send software stocks tumbling. Pharmaceutical…
Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
The project was initiated at the Piramal Pharmaceutical Development Services (PPDS) site in Ahmedabad. Within just five months, the site team completed a successful tech transfer to Piramal's commercial manufacturing site in Pithampur inclusive of…
GIFT City, gems & jewellery, real estate, pharma and healthcare, snack, education: What Gujarat industry & Service sector leaders said about the 2026-27 Union budget
Kirit Bhansali, Chairman, Gem & Jewellery Export Promotion Council (GJEPC) “THE UNION Budget addresses key bottlenecks and gives fresh momentum to India's gems and jewellery sector. It improves liquidity, supports manufacturing and…
Marshall Urist Sells 20,000 Shares of Royalty Pharma (NASDAQ:RPRX) Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 20,000 shares of the stock in a transaction dated Friday, January 30th. The stock was sold at an average price of $41.09, for a total value of $821,800.00. The sale was…
Principal Financial Group Inc. Grows Position in Ascendis Pharma A/S $ASND
Principal Financial Group Inc. lifted its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 2,722.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The…
Health Ministry discusses reactivating and revitalizing the national pharmaceutical industry
Libya's Tripoli based Ministry of Health is discussing reactivating the local pharmaceutical industry. This came during the holding of the first meeting of the Board of Directors of the General Company for Pharmaceutical Industries and Medical…
Paul Mueller Company Is Wonderfully Compelling (OTCMKTS:MUEL)
Paul Mueller Company offers a compelling value proposition with strong growth, a robust balance sheet, and deep operating diversification. MUEL has achieved significant revenue and profit expansion, driven primarily by its Industrial Equipment…
Fintech CEO and Forbes 30 Under 30 alum has been charged for alleged fraud
By now, the Forbes 30 Under 30 list has become more than a little notorious for the amount of entrants who go on to be charged with fraud. Notable alumni include FTX founder Sam Bankman-Fried, Frank CEO Charlie Javice, Joanna Smith-Griffin, founder…
Can PR help solve the women's health crisis?
Women in all parts of my life are encountering similar obstacles in their health journeys. The common thread is that when we don't advocate for ourselves and ask the right questions, we don't get the care we need. While volunteering as a women's…
Rajasthan fully prepared to take advantage of budgetary incentives: CM
Rajasthan is fully prepared to take advantage of new budgetary provisions and incentives, as the Union Budget for 2026-27 has placed the State in the mainstream of national development, Chief Minister Bhajan Lal Sharma said in Jaipur on Monday…
'Marketplace for predators': Meta faces jury trial over child exploitation claims
Meta's second major trial of 2026 over alleged harms to children begins on Monday. The landmark jury trial in Santa Fe pits the New Mexico attorney general's office against the social media giant. The state alleges that the company knowingly…
PhaseV Launches AI-Powered Enrollment Lab: Eliminating Guesswork and Grounding Study Design in Clinical Reality
'With the AI Enrollment Lab, we are replacing theoretical planning with evidence-based certainty much earlier in the development lifecycle,' said Raviv Pryluk, PhD, CEO and Co-founder of PhaseV. 'By uncovering enrollment constraints and trade-offs…
Top Growth Stocks To Consider - February 2nd
3 Robotics Stocks Animating Markets With Ample Upside to Go Teledyne Technologies, Prologis, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies…
Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year
Merck & Co. reports Q4 2025 earnings on Tuesday, Feb. 3, 2026, before market open. Wall Street expects earnings of $2.01 per share on revenue of $16.12 billion, representing 3.1% year-over-year growth. Shares have gained 13% over the past year…
Receive a Daily briefing on Pharma Industry News
Get Started